Accepted for/Published in: JMIR Research Protocols
Date Submitted: Feb 21, 2025
Date Accepted: Oct 1, 2025
The Effect of Virtual Reality-based Social Cognitive Training for Autistic Adults: A Study Protocol for STEPS (Social Cognitive Training Enhancing Pro-functional Skills), a Randomised Clinical Trial
ABSTRACT
Background:
Autistic adults (AA) constitute a growing and largely overlooked population with limited clinical and research resources. Social cognitive impairments are key deficits faced by this population, significantly impacting social interactions, educational and vocational functioning, and quality of life. Interventions targeting social cognition in AA have shown promising results. Recent studies investigating the effect of virtual reality (VR)-based interventions for AA have provided preliminary evidence supporting the feasibility and effectiveness of utilizing this innovative technology. These studies indicate that VR-interventions can enhance functional and social skills and improve specific neurocognitive and social cognitive functions. However, large-scale randomised clinical trials are urgently needed to fully assess the effectiveness of VR-based interventions for AA.
Objective:
This protocol aims to provide a comprehensive description of the design and methodology of the STEPS (Social cognitive Training Enhancing Pro-functional Skills) trial.
Methods:
STEPS is a clinical, randomised, assessor-blinded, parallel-group superiority trial. A total of 140 participants will be allocated to receive either virtual reality-based social cognitive training (VRSCT) + treatment as usual (TAU), or TAU alone. The experimental group will receive 12 weekly one-hour sessions of VRSCT aiming at improving psychosocial functioning and social cognition through exposure to virtual social environments. The intervention comprises three core modules: Emotions, Social Understanding, and Complex Social Interactions. The exact content and duration of TAU will be documented prospectively throughout the trial and summarised upon completion. Assessments will be conducted at baseline, at cessation of the intervention (3 months post-baseline), and at 6 months post-baseline.
Results:
The trial is currently recruiting participants. The first participant was enrolled in May 2024. Completion of recruitment is expected in January March 2026. Data analysis is expected to commence in summer autumn 2026, following the final six-month follow-up assessment. Results are anticipated by in autumn winter 2026 and will be disseminated at international conferences and through peer-reviewed publications.
Conclusions:
To our knowledge, STEPS is the hitherto largest randomised clinical trial globally investigating the effect of VRSCT for AA. The results of this innovative intervention approach may significantly advance research in the field of autism. VRSCT holds potential to improve psychosocial functioning, quality of life, co-occurring clinical symptoms and to reduce social cognitive deficits in AA. Establishing evidence-based interventions is crucial for addressing the debilitating psychosocial challenges faced by this population, especially considering the absence of established gold-standard treatments. Clinical Trial: Registered at ClinicalTrials.gov (ID: NCT06438536). https://clinicaltrials.gov/study/NCT06438536?term=NCT06438536&rank=1
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.